Invesco Ltd. Seres Therapeutics, Inc. Transaction History

Invesco Ltd.

$499 Billion
Q3 2024

A detailed history of Invesco Ltd. transactions in Seres Therapeutics, Inc. stock. As of the latest transaction made, Invesco Ltd. holds 55,218 shares of MCRB stock, worth $54,113. This represents 0.0% of its overall portfolio holdings.

Number of Shares

55,218

Previous 39,259 40.65%

Holding current value

$54,113

Previous $28,000 85.71%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$0.7 - $1.48 $11,171 - $23,619	15,959 Added 40.65%	55,218 $52,000
Q2 2024 Aug 13, 2024	SELL	$0.56 - $1.19 $13,275 - $28,211	-23,707 Reduced 37.65%	39,259 $28,000
Q1 2024 May 14, 2024	BUY	$0.75 - $1.56 $4,474 - $9,306	5,966 Added 10.47%	62,966 $48,000
Q4 2023 Feb 12, 2024	BUY	$0.93 - $2.15 $12,687 - $29,330	13,642 Added 31.46%	57,000 $79,000
Q3 2023 Nov 13, 2023	BUY	$2.33 - $5.07 $5,270 - $11,468	2,262 Added 5.5%	43,358 $103,000
Q2 2023 Aug 11, 2023	BUY	$4.67 - $6.55 $28,342 - $39,751	6,069 Added 17.33%	41,096 $196,000
Q1 2023 May 12, 2023	BUY	$4.95 - $6.09 $4,123 - $5,072	833 Added 2.44%	35,027 $198,000
Q4 2022 Feb 13, 2023	SELL	$5.09 - $9.05 $2.73 Million - $4.85 Million	-535,403 Reduced 94.0%	34,194 $191,000
Q3 2022 Nov 14, 2022	BUY	$3.5 - $7.2 $1.89 Million - $3.88 Million	538,849 Added 1752.47%	569,597 $3.66 Million
Q2 2022 Aug 15, 2022	SELL	$2.7 - $7.62 $2,640 - $7,452	-978 Reduced 3.08%	30,748 $106,000
Q1 2022 May 16, 2022	SELL	$6.3 - $8.84 $18 - $26	-3 Reduced 0.01%	31,726 $225,000
Q4 2021 Feb 14, 2022	SELL	$6.02 - $11.43 $51,290 - $97,383	-8,520 Reduced 21.17%	31,729 $264,000
Q3 2021 Nov 15, 2021	BUY	$5.46 - $22.6 $36,057 - $149,250	6,604 Added 19.63%	40,249 $281,000
Q2 2021 Aug 17, 2021	BUY	$18.46 - $24.36 $352,346 - $464,959	19,087 Added 131.11%	33,645 $802,000
Q1 2021 May 17, 2021	BUY	$17.66 - $28.92 $73,624 - $120,567	4,169 Added 40.13%	14,558 $300,000
Q4 2020 Feb 16, 2021	SELL	$23.25 - $37.73 $1.48 Million - $2.4 Million	-63,556 Reduced 85.95%	10,389 $254,000
Q3 2020 Nov 16, 2020	BUY	$3.74 - $28.74 $276,554 - $2.13 Million	73,945 New	73,945 $2.09 Million

Others Institutions Holding MCRB

# of Institutions

Shares Held

40.5M

Call Options Held

304K

Put Options Held

471K

View Full List

About Seres Therapeutics, Inc.

Ticker MCRB
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 124,072,000
Market Cap $122M
Description
Seres Therapeutics, Inc., a microbiome therapeutics platform company, engages in developing bacterial consortia that are designed to functionally interact with host cells and tissues to treat disease. The company's lead product candidate is the SER-109, an oral microbiome therapeutic candidate that has completed Phase III clinical trial for the ...

More about MCRB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

News

Stay updated on Invesco Ltd. with notifications on news.

Account